and competition with invasive species.

among those rooting for PSG against Italy’s Inter Milan, and he hoped to be able to tune in on TV to watch the big clash that’ll be held in Munich, Germany. So Djokovic made that preference known to the people in charge of arranging the program at the clay-court— a common practice, especially among the sport’s elite.

They often ask to be scheduled at a certain time. Or to avoid a certain time.“I will definitely watch it if I’m not playing (in the) night session. Yeah, that will be nice,” Djokovic said with a big smile. “FYI, Roland-Garros schedule.”Hint, hint. Except his plea went unheeded: When Saturday’s order of play was released Friday, 24-time major champion

was the one picked for under the lights at Court Philippe-Chatrier due to begin at 8:15 p.m. local time, 45 minutes before Inter Milan vs. PSG starts.Others who begged off from competing at that hour got their wish. Although one, Arthur Fils, the 14th-seeded Frenchman who grew up near Paris and is a big PSG fan, wound up pulling out of the tournament

after being placed in an afternoon match against No. 17 Andrey Rublev.

“We have many requests from players” every day,, most of them caused by a misstep hidden within their genes. Some conditions can be caught early and treated—but in parts of Africa where population data and resources are scarce, many people go undiagnosed. Rodriguez is trying to change that by connecting patients with genetic testing and medical support, while gathering key data from those patients and their families.

“Most rare disease data has been collected from people of European ancestry, so we have very little knowledge about what’s happening in other parts of the world, mainly in Africa,” Rodriguez said.Ndeye Lam looks at photos of her deceased daughter Mariama who died at age 13 of a rare genetic disease, in Dakar, Senegal, Saturday, Jan. 11, 2025. (AP Photo/Annika Hammerschlag)

Ndeye Lam looks at photos of her deceased daughter Mariama who died at age 13 of a rare genetic disease, in Dakar, Senegal, Saturday, Jan. 11, 2025. (AP Photo/Annika Hammerschlag)His research is funded by organizations including the La Caixa Foundation in Spain and the National Ataxia Foundation in the United States. And he has consulted with scientists in China, France, Boston, and elsewhere around the world, documenting rare diseases and novel disease-causing gene variants.